UBS Group AG - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 42 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$3,0000.0%11,155
+320.9%
0.00%
Q4 2017$3,000
-50.0%
2,650
-2.2%
0.00%
Q3 2017$6,000
-60.0%
2,710
-47.2%
0.00%
Q2 2017$15,000
-11.8%
5,129
+0.9%
0.00%
Q1 2017$17,000
+183.3%
5,083
+37.0%
0.00%
Q4 2016$6,000
-50.0%
3,710
+2.8%
0.00%
Q3 2016$12,0003,6100.00%
Other shareholders

There were no reported owners of OREXIGEN THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of OREXIGEN THERAPEUTICS INC shareholders